benlye
2021-08-10
yea. get a virus to the world. pharma companies earn money. whats new
Moderna Is Now Valued Higher Than 130-Year Old Vaccine Giant Merck
免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。
分享至
微信
复制链接
精彩评论
我们需要你的真知灼见来填补这片空白
打开APP，发表看法
APP内打开
发表看法
1
2
{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":896203031,"tweetId":"896203031","gmtCreate":1628582621023,"gmtModify":1631894035122,"author":{"id":3567752858658977,"idStr":"3567752858658977","authorId":3567752858658977,"authorIdStr":"3567752858658977","name":"benlye","avatar":"https://static.tigerbbs.com/cdeeb14b6e0a3873563f8b6c5c96dd80","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":8,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":26,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>yea. get a virus to the world. pharma companies earn money. whats new</p></body></html>","htmlText":"<html><head></head><body><p>yea. get a virus to the world. pharma companies earn money. whats new</p></body></html>","text":"yea. get a virus to the world. pharma companies earn money. whats new","highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/896203031","repostId":1162182331,"repostType":4,"repost":{"id":"1162182331","kind":"news","pubTimestamp":1628582107,"share":"https://ttm.financial/m/news/1162182331?lang=&edition=full","pubTime":"2021-08-10 15:55","market":"us","language":"en","title":"Moderna Is Now Valued Higher Than 130-Year Old Vaccine Giant Merck","url":"https://stock-news.laohu8.com/highlight/detail?id=1162182331","media":"Benzinga","summary":"Moderna Inc, a company founded in 2010, is now worth more than the 130-year old Merck & Co., Inc in ","content":"<p><b>Moderna Inc</b>, a company founded in 2010, is now worth more than the 130-year old <b>Merck & Co., Inc</b> in terms of market capitalization.</p>\n<p><b>What Happened:</b>Moderna’s shares spiked Monday amid a string of positive news including being grantedprovisional registration by the <b>Australian Therapeutic Goods Administration</b> for its COVID-19 vaccine.</p>\n<p>Moderna shares shot up 17.10% to $484.47 in Monday’s regular session and rose another 0.32% in the after-hours trading.</p>\n<p>The Massachusetts-based purveyor of MRNA COVID-19 vaccines has a market capitalization of $195.55 billion at press time.</p>\n<p>In comparison — Merck, a pharmaceutical major founded in 1891, has a market capitalization of $190.71 billion.</p>\n<p>In Monday’s regular session, Merck saw its shares close 0.16% lower at $75.32.</p>\n<p><b>Why It Matters:</b>It was only last year in January that Moderna developed its COVID-19 vaccine candidate <b>mRNA-1273</b>in a record two days, while the same process can take years using more traditional methods.</p>\n<p>The first volunteer received the test shot on March 16 as Moderna became the first company in the world to launch a clinical trial of a COVID-19 vaccine candidate.</p>\n<p>In December 2020, the Moderna COVID-19 vaccine received the nod from an advisory panel of the U.S. Food and Drug Administration, which cleared the way for it toreceivean Emergency Use Authorization.</p>\n<p>In its second-quarter earnings report, Moderna noted that its vaccine continues to be 93% effective six months after the second dose.</p>\n<p><b>Pfizer Inc</b>/<b>BioNTech SE</b>,which use similar mRNA technology for their vaccine, said the COVID-19 vaccine efficacy declined to 84% after six months.</p>\n<p>Oppenheimer analyst Hartaj Singh noted last week that Moderna now has thephysical and human capital to rapidly investin its business with COVID-19 vaccine sales fueling its future growth.</p>","source":"lsy1606299360108","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna Is Now Valued Higher Than 130-Year Old Vaccine Giant Merck</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna Is Now Valued Higher Than 130-Year Old Vaccine Giant Merck\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-10 15:55 GMT+8 <a href=https://www.benzinga.com/general/biotech/21/08/22413844/moderna-is-now-valued-higher-than-130-year-old-vaccine-giant-merck><strong>Benzinga</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Moderna Inc, a company founded in 2010, is now worth more than the 130-year old Merck & Co., Inc in terms of market capitalization.\nWhat Happened:Moderna’s shares spiked Monday amid a string of ...</p>\n\n<a href=\"https://www.benzinga.com/general/biotech/21/08/22413844/moderna-is-now-valued-higher-than-130-year-old-vaccine-giant-merck\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.benzinga.com/general/biotech/21/08/22413844/moderna-is-now-valued-higher-than-130-year-old-vaccine-giant-merck","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1162182331","content_text":"Moderna Inc, a company founded in 2010, is now worth more than the 130-year old Merck & Co., Inc in terms of market capitalization.\nWhat Happened:Moderna’s shares spiked Monday amid a string of positive news including being grantedprovisional registration by the Australian Therapeutic Goods Administration for its COVID-19 vaccine.\nModerna shares shot up 17.10% to $484.47 in Monday’s regular session and rose another 0.32% in the after-hours trading.\nThe Massachusetts-based purveyor of MRNA COVID-19 vaccines has a market capitalization of $195.55 billion at press time.\nIn comparison — Merck, a pharmaceutical major founded in 1891, has a market capitalization of $190.71 billion.\nIn Monday’s regular session, Merck saw its shares close 0.16% lower at $75.32.\nWhy It Matters:It was only last year in January that Moderna developed its COVID-19 vaccine candidate mRNA-1273in a record two days, while the same process can take years using more traditional methods.\nThe first volunteer received the test shot on March 16 as Moderna became the first company in the world to launch a clinical trial of a COVID-19 vaccine candidate.\nIn December 2020, the Moderna COVID-19 vaccine received the nod from an advisory panel of the U.S. Food and Drug Administration, which cleared the way for it toreceivean Emergency Use Authorization.\nIn its second-quarter earnings report, Moderna noted that its vaccine continues to be 93% effective six months after the second dose.\nPfizer Inc/BioNTech SE,which use similar mRNA technology for their vaccine, said the COVID-19 vaccine efficacy declined to 84% after six months.\nOppenheimer analyst Hartaj Singh noted last week that Moderna now has thephysical and human capital to rapidly investin its business with COVID-19 vaccine sales fueling its future growth.","news_type":1,"symbols_score_info":{"BNTX":0.9,"MRK":0.9,"MRNA":0.9,"PFE":0.9}},"isVote":1,"tweetType":1,"viewCount":470,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":57,"xxTargetLangEnum":"ORIG"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/896203031"}
精彩评论